John S. Barresi - 28 Feb 2025 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Mar 2025, 16:08:20 UTC
Prior SEC filing
28 Feb 2025
Next SEC filing
03 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brianna M. Cetrulo, attorney-in-fact

Key filing fact

John S. Barresi filed Form 4 for Bausch Health Companies Inc. (BHC) on 03 Mar 2025.

Key facts

  • This page summarizes John S. Barresi's Form 4 filing for Bausch Health Companies Inc. (BHC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Mar 2025, 16:08.

Change

  • Previous filing in this sequence was filed on 28 Feb 2025.
  • Current net transaction value: -$59,230.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value
$21,316
Shares
-2,865
Change %
-1.4%
Price
$7.44
Shares after
197,364
Date
28 Feb 2025
Ownership
Direct
Footnotes
F1
BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value
$37,914
Shares
-5,096
Change %
-2.6%
Price
$7.44
Shares after
192,268
Date
28 Feb 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .